Alzheimer’s drug development pipeline: Promising therapies, pharma investment drive momentum in clinical trials


More than 6 million Americans are living with Alzheimer’s disease, a staggering number that’s expected to double within the next 30 years.

Multiple sclerosis: Ultrastructural changes in brain tissue promote inflammatory processes

Previous article

Stretchable knee wearable offers insight into improving e-textiles for health care

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations